Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell–mediated elimination of tumor cells
Top Cited Papers
- 1 January 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 105 (1) , 178-185
- https://doi.org/10.1182/blood-2004-06-2272
Abstract
To test the hypothesis that platelet activation contributes to tumor dissemination, we studied metastasis in mice lacking Gαq, a G protein critical for platelet activation. Loss of platelet activation resulted in a profound diminution in both experimental and spontaneous metastases. Analyses of the distribution of radiolabeled tumor cells demonstrated that platelet function, like fibrinogen, significantly improved the survival of circulating tumor cells in the pulmonary vasculature. More detailed studies showed that the increase in metastatic success conferred by either platelets or fibrinogen was linked to natural killer cell function. Specifically, the pronounced reduction in tumor cell survival observed in fibrinogen- and Gαq-deficient mice relative to control animals was eliminated by the immunologic or genetic depletion of natural killer cells. These studies establish an important link between hemostatic factors and innate immunity and indicate that one mechanism by which the platelet-fibrin(ogen) axis contributes to metastatic potential is by impeding natural killer cell elimination of tumor cells.Keywords
This publication has 28 references indexed in Scilit:
- Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasisBlood, 2004
- Antibody blockade or mutation of the fibrinogen γ-chain C-terminus is more effective in inhibiting murine arterial thrombus formation than complete absence of fibrinogenBlood, 2004
- Platelets in Inflammation and ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patencyBlood, 2003
- Platelet Chemokines and Chemokine Receptors: Linking Hemostasis, Inflammation, and Host DefenseMicrocirculation, 2003
- Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454Thrombosis and Haemostasis, 2003
- Myeloablation enhances engraftment of transduced murine hematopoietic cells, but does not influence long-term expression of the transgeneGene Therapy, 2002
- Platelets and cancer metastasis: A causal relationship?Cancer and Metastasis Reviews, 1992
- Effects of antiplatelet agents alone or in combinations on platelet aggregation and on liver metastases from a human pancreatic adenocarcinoma in the nude mouseJournal of Surgical Oncology, 1991
- Prostacyclin: A Potent Antimetastatic AgentScience, 1981